SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001493152-21-020817
Filing Date
2021-08-20
Accepted
2021-08-20 16:30:50
Documents
16
Period of Report
2021-08-20
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 form8-k.htm   iXBRL 8-K 40554
2 ex1-1.htm EX-1.1 275261
3 ex5-1.htm EX-5.1 21772
4 ex5-1_001.jpg GRAPHIC 7375
5 ex5-1_002.jpg GRAPHIC 6567
  Complete submission text file 0001493152-21-020817.txt   595428

Data Files

Seq Description Document Type Size
6 XBRL SCHEMA FILE pcsa-20210820.xsd EX-101.SCH 3069
7 XBRL LABEL FILE pcsa-20210820_lab.xml EX-101.LAB 34239
8 XBRL PRESENTATION FILE pcsa-20210820_pre.xml EX-101.PRE 22388
9 EXTRACTED XBRL INSTANCE DOCUMENT form8-k_htm.xml XML 3662
Mailing Address 7380 COCA COLA DRIVE SUITE 106 HANOVER MD 21076
Business Address 7380 COCA COLA DRIVE SUITE 106 HANOVER MD 21076 443-776-3133
Processa Pharmaceuticals, Inc. (Filer) CIK: 0001533743 (see all company filings)

IRS No.: 451539785 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-39531 | Film No.: 211194228
SIC: 2834 Pharmaceutical Preparations